Miguel De Los Rios

Miguel de Los Rios is a passionate entrepreneur focused on building and developing novel therapeutics to satisfy unmet needs in human medicine. He received his Ph.D. In biophysical chemistry and a BS in cell biology, both at UCSB. Currently, Miguel is CEO and co-founder of Endeavor Biomedicines. He was previously founding CEO at Rift Biotherapeutics, a therapeutic antibody company focused on modulating novel mechanisms to ignite the immune system against cancers. Miguel also served as Vice President of Research and Development at Sevion Therapeutics (formerly Fabrus, Inc.), a clinical-stage therapeutics company focused on oncology and autoimmune disorders. Miguel founded Chimeros, Inc., a venture-backed biologics therapeutic company in 2003 while working to complete his Ph.D. at UCSB. At Chimeros, he served as both the Chief Executive Officer as well as the Chief Scientific Officer from 2003-2011 and was the inventor of the company’s core technologies. He continues to build and help launch companies whose missions are to radically disrupt current medical approaches. Miguel is a council member of the University of California Innovations Council where he works the entire UC system to aid system-wide innovation. He also advises several start-up biotechnology companies and venture capital firms. Miguel is the lead author or inventor on 50 publications, patents, and patent applications. He is also the founding blacksmith at Angel’s Forge.